Moreover, the path length for APP/PS1 and 3xTg-AD mice to find the platform was longer than that of PBMT-treated mice, respectively (Fig. 1C), suggesting that PBMT-treated lymph nodes of AD mice significantly improved learning deficits. Here, APP is linked to Alzheimer disease.